 Rebecca Ihrie
Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lateral Ventricles | 11 | 2023 | 32 | 3.900 |
Why?
| | Neural Stem Cells | 12 | 2025 | 166 | 3.880 |
Why?
| | Tuberous Sclerosis | 5 | 2025 | 56 | 3.100 |
Why?
| | Stem Cell Niche | 4 | 2021 | 58 | 2.290 |
Why?
| | Glioblastoma | 9 | 2025 | 353 | 1.920 |
Why?
| | Brain Neoplasms | 9 | 2025 | 1322 | 1.800 |
Why?
| | Hedgehog Proteins | 4 | 2018 | 197 | 1.310 |
Why?
| | Neurogenesis | 4 | 2019 | 157 | 1.070 |
Why?
| | Adult Stem Cells | 3 | 2022 | 39 | 1.060 |
Why?
| | Brain | 9 | 2026 | 2941 | 1.050 |
Why?
| | Signal Transduction | 11 | 2025 | 5233 | 0.990 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 4 | 2025 | 139 | 0.950 |
Why?
| | DNA Methylation | 3 | 2025 | 683 | 0.870 |
Why?
| | Membrane Proteins | 8 | 2011 | 1167 | 0.810 |
Why?
| | Zinc Finger Protein Gli3 | 1 | 2022 | 3 | 0.720 |
Why?
| | Oligodendrocyte Transcription Factor 2 | 1 | 2022 | 23 | 0.710 |
Why?
| | Microscopy | 1 | 2023 | 156 | 0.690 |
Why?
| | Printing, Three-Dimensional | 1 | 2021 | 96 | 0.630 |
Why?
| | Astrocytoma | 2 | 2019 | 129 | 0.630 |
Why?
| | Phosphoproteins | 4 | 2006 | 346 | 0.590 |
Why?
| | Trans-Activators | 4 | 2006 | 405 | 0.580 |
Why?
| | Cell Lineage | 4 | 2025 | 376 | 0.570 |
Why?
| | Nerve Tissue Proteins | 1 | 2022 | 592 | 0.540 |
Why?
| | Single-Cell Analysis | 5 | 2026 | 359 | 0.530 |
Why?
| | Morphogenesis | 1 | 2018 | 173 | 0.530 |
Why?
| | Flow Cytometry | 6 | 2024 | 1173 | 0.520 |
Why?
| | Software | 1 | 2023 | 692 | 0.520 |
Why?
| | Imaging, Three-Dimensional | 1 | 2021 | 583 | 0.510 |
Why?
| | Carcinogenesis | 1 | 2019 | 229 | 0.510 |
Why?
| | Glioma | 1 | 2021 | 426 | 0.490 |
Why?
| | Tumor Suppressor Protein p53 | 4 | 2006 | 531 | 0.490 |
Why?
| | Desmosomes | 3 | 2011 | 22 | 0.470 |
Why?
| | Cell Differentiation | 8 | 2025 | 2050 | 0.460 |
Why?
| | Neurons | 6 | 2020 | 1642 | 0.440 |
Why?
| | Animals | 28 | 2025 | 38109 | 0.440 |
Why?
| | Sirtuin 1 | 1 | 2014 | 34 | 0.430 |
Why?
| | Synapses | 1 | 2018 | 439 | 0.430 |
Why?
| | Mice | 21 | 2025 | 18365 | 0.380 |
Why?
| | Induced Pluripotent Stem Cells | 3 | 2025 | 276 | 0.380 |
Why?
| | Tumor Microenvironment | 5 | 2025 | 735 | 0.370 |
Why?
| | Medulloblastoma | 1 | 2014 | 215 | 0.360 |
Why?
| | Cerebral Ventricles | 1 | 2011 | 54 | 0.340 |
Why?
| | Proto-Oncogene Proteins | 1 | 2014 | 623 | 0.340 |
Why?
| | Repressor Proteins | 1 | 2014 | 437 | 0.340 |
Why?
| | Drug Resistant Epilepsy | 2 | 2026 | 137 | 0.340 |
Why?
| | Astrocytes | 3 | 2025 | 224 | 0.320 |
Why?
| | Cell Movement | 2 | 2011 | 965 | 0.310 |
Why?
| | Humans | 36 | 2026 | 144957 | 0.300 |
Why?
| | Apoptosis | 7 | 2019 | 2430 | 0.300 |
Why?
| | Neoplasms | 6 | 2022 | 2884 | 0.290 |
Why?
| | DNA-Binding Proteins | 2 | 2014 | 1500 | 0.290 |
Why?
| | Malformations of Cortical Development | 2 | 2026 | 19 | 0.280 |
Why?
| | Smoothened Receptor | 2 | 2022 | 5 | 0.270 |
Why?
| | Stem Cells | 2 | 2011 | 627 | 0.250 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2011 | 906 | 0.250 |
Why?
| | Gene Expression Profiling | 3 | 2023 | 1786 | 0.240 |
Why?
| | Ectodermal Dysplasia | 1 | 2006 | 19 | 0.240 |
Why?
| | Image Cytometry | 2 | 2022 | 12 | 0.230 |
Why?
| | DNA Demethylation | 1 | 2025 | 4 | 0.230 |
Why?
| | Benzofurans | 1 | 2025 | 26 | 0.230 |
Why?
| | Tumor Suppressor Proteins | 2 | 2023 | 321 | 0.220 |
Why?
| | Mouth Mucosa | 1 | 2005 | 88 | 0.220 |
Why?
| | Cell Proliferation | 7 | 2025 | 2499 | 0.210 |
Why?
| | Cells, Cultured | 4 | 2022 | 4155 | 0.210 |
Why?
| | Hypercholesterolemia | 1 | 2025 | 93 | 0.210 |
Why?
| | Microglia | 2 | 2023 | 269 | 0.210 |
Why?
| | Enhancer Elements, Genetic | 1 | 2025 | 192 | 0.200 |
Why?
| | Cell Adhesion | 5 | 2011 | 455 | 0.200 |
Why?
| | Skin | 2 | 2006 | 758 | 0.200 |
Why?
| | Blood-Brain Barrier | 1 | 2024 | 155 | 0.190 |
Why?
| | Olfactory Bulb | 2 | 2015 | 97 | 0.180 |
Why?
| | Disease Susceptibility | 2 | 2019 | 348 | 0.180 |
Why?
| | Neoplastic Stem Cells | 2 | 2021 | 412 | 0.180 |
Why?
| | Biological Products | 1 | 2025 | 252 | 0.180 |
Why?
| | Nestin | 1 | 2021 | 19 | 0.170 |
Why?
| | Atherosclerosis | 1 | 2025 | 409 | 0.170 |
Why?
| | Chromatin | 1 | 2025 | 561 | 0.170 |
Why?
| | Interneurons | 1 | 2022 | 128 | 0.160 |
Why?
| | Oligodendroglioma | 1 | 2020 | 15 | 0.160 |
Why?
| | Cell Nucleus | 2 | 2023 | 619 | 0.160 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2023 | 781 | 0.160 |
Why?
| | Immunohistochemistry | 2 | 2023 | 1718 | 0.160 |
Why?
| | Unsupervised Machine Learning | 1 | 2020 | 22 | 0.160 |
Why?
| | Macrophages | 2 | 2025 | 1511 | 0.160 |
Why?
| | GTPase-Activating Proteins | 1 | 2020 | 82 | 0.160 |
Why?
| | Organoids | 1 | 2022 | 141 | 0.160 |
Why?
| | X-Ray Therapy | 1 | 2019 | 2 | 0.160 |
Why?
| | Corpus Callosum | 2 | 2017 | 72 | 0.150 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 16 | 0.150 |
Why?
| | Mice, Knockout | 7 | 2025 | 3125 | 0.150 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2025 | 1141 | 0.140 |
Why?
| | Cell Line, Tumor | 4 | 2025 | 3550 | 0.140 |
Why?
| | Datasets as Topic | 1 | 2019 | 122 | 0.140 |
Why?
| | Animals, Newborn | 1 | 2021 | 902 | 0.140 |
Why?
| | Biomarkers, Tumor | 1 | 2025 | 1322 | 0.140 |
Why?
| | Machine Learning | 1 | 2024 | 587 | 0.140 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 239 | 0.130 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2019 | 1462 | 0.130 |
Why?
| | Mutation | 2 | 2026 | 4099 | 0.130 |
Why?
| | Genes, Reporter | 1 | 2017 | 276 | 0.120 |
Why?
| | Transgenes | 1 | 2017 | 190 | 0.120 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5997 | 0.120 |
Why?
| | Zinc Finger Protein GLI1 | 2 | 2015 | 26 | 0.120 |
Why?
| | Macrolides | 1 | 2016 | 69 | 0.120 |
Why?
| | Survival Analysis | 1 | 2019 | 1385 | 0.110 |
Why?
| | Mass Spectrometry | 1 | 2019 | 750 | 0.110 |
Why?
| | Angelman Syndrome | 1 | 2015 | 10 | 0.110 |
Why?
| | Genomic Imprinting | 1 | 2015 | 26 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 11 | 0.110 |
Why?
| | Kruppel-Like Transcription Factors | 2 | 2015 | 78 | 0.110 |
Why?
| | Female | 10 | 2026 | 78376 | 0.110 |
Why?
| | Epithelium | 2 | 2006 | 314 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 1 | 2016 | 966 | 0.100 |
Why?
| | ErbB Receptors | 1 | 2017 | 629 | 0.100 |
Why?
| | Age Factors | 2 | 2011 | 3335 | 0.100 |
Why?
| | Transcription Factors | 2 | 2016 | 1742 | 0.100 |
Why?
| | Oligodendroglia | 1 | 2015 | 187 | 0.100 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2015 | 193 | 0.100 |
Why?
| | Phenotype | 2 | 2025 | 3164 | 0.100 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 73 | 0.090 |
Why?
| | Proteomics | 1 | 2019 | 1195 | 0.090 |
Why?
| | Calbindins | 1 | 2011 | 6 | 0.090 |
Why?
| | Stilbamidines | 1 | 2011 | 9 | 0.090 |
Why?
| | S100 Calcium Binding Protein G | 1 | 2011 | 8 | 0.090 |
Why?
| | Choline O-Acetyltransferase | 1 | 2011 | 25 | 0.090 |
Why?
| | Germ Layers | 1 | 2011 | 6 | 0.090 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2011 | 71 | 0.090 |
Why?
| | Estrogen Antagonists | 1 | 2011 | 48 | 0.090 |
Why?
| | Cytarabine | 1 | 2011 | 66 | 0.090 |
Why?
| | Odontogenesis | 1 | 2011 | 11 | 0.080 |
Why?
| | Dental Enamel | 1 | 2011 | 67 | 0.080 |
Why?
| | Sirolimus | 2 | 2024 | 281 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2021 | 2738 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1958 | 0.080 |
Why?
| | Tamoxifen | 1 | 2011 | 217 | 0.080 |
Why?
| | Luminescent Proteins | 1 | 2011 | 185 | 0.080 |
Why?
| | Circadian Rhythm | 1 | 2015 | 514 | 0.080 |
Why?
| | Gene Expression | 2 | 2015 | 1490 | 0.080 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2012 | 226 | 0.080 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2011 | 233 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2012 | 930 | 0.070 |
Why?
| | Male | 7 | 2025 | 72406 | 0.070 |
Why?
| | Disease Progression | 1 | 2016 | 2852 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2011 | 2185 | 0.070 |
Why?
| | Heterozygote | 2 | 2006 | 315 | 0.070 |
Why?
| | Adult | 5 | 2025 | 40506 | 0.070 |
Why?
| | Blotting, Northern | 2 | 2004 | 204 | 0.060 |
Why?
| | Immunosuppressive Agents | 1 | 2011 | 847 | 0.060 |
Why?
| | Child, Preschool | 2 | 2019 | 11799 | 0.060 |
Why?
| | Hair | 1 | 2006 | 88 | 0.060 |
Why?
| | Child | 4 | 2020 | 22657 | 0.060 |
Why?
| | Papilloma | 1 | 2005 | 49 | 0.060 |
Why?
| | Desmoplakins | 1 | 2005 | 24 | 0.060 |
Why?
| | Genes, Tumor Suppressor | 1 | 2005 | 83 | 0.060 |
Why?
| | Epidermis | 1 | 2006 | 157 | 0.060 |
Why?
| | CpG Islands | 1 | 2025 | 165 | 0.050 |
Why?
| | Cytoskeletal Proteins | 1 | 2005 | 156 | 0.050 |
Why?
| | Structure-Activity Relationship | 1 | 2025 | 570 | 0.050 |
Why?
| | Molecular Structure | 1 | 2025 | 501 | 0.050 |
Why?
| | Blotting, Southern | 1 | 2003 | 85 | 0.050 |
Why?
| | In Situ Nick-End Labeling | 1 | 2003 | 121 | 0.050 |
Why?
| | Keratinocytes | 1 | 2005 | 250 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2026 | 437 | 0.050 |
Why?
| | Mutant Proteins | 1 | 2023 | 106 | 0.050 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2025 | 266 | 0.050 |
Why?
| | Mice, Mutant Strains | 1 | 2003 | 299 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2011 | 2832 | 0.050 |
Why?
| | Phagocytes | 1 | 2023 | 81 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2004 | 167 | 0.050 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2025 | 452 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2011 | 2609 | 0.040 |
Why?
| | Phagocytosis | 1 | 2023 | 299 | 0.040 |
Why?
| | Fetal Development | 1 | 2005 | 299 | 0.040 |
Why?
| | Receptors, Cell Surface | 1 | 2023 | 377 | 0.040 |
Why?
| | Adolescent | 2 | 2019 | 22453 | 0.040 |
Why?
| | Lymphocytes | 1 | 2023 | 382 | 0.040 |
Why?
| | Cell Separation | 2 | 2017 | 307 | 0.040 |
Why?
| | Hepatocytes | 2 | 2017 | 224 | 0.040 |
Why?
| | Erlotinib Hydrochloride | 1 | 2020 | 72 | 0.040 |
Why?
| | Microscopy, Fluorescence | 2 | 2017 | 418 | 0.040 |
Why?
| | Myocardium | 1 | 2006 | 939 | 0.040 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2022 | 285 | 0.040 |
Why?
| | Time Factors | 1 | 2011 | 7183 | 0.040 |
Why?
| | Haploinsufficiency | 1 | 2020 | 55 | 0.040 |
Why?
| | Remission Induction | 1 | 2020 | 308 | 0.040 |
Why?
| | Antineoplastic Agents, Alkylating | 1 | 2019 | 72 | 0.040 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2019 | 56 | 0.040 |
Why?
| | Drug Resistance | 1 | 2019 | 153 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2020 | 919 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 241 | 0.030 |
Why?
| | Mice, SCID | 2 | 2012 | 369 | 0.030 |
Why?
| | Skin Neoplasms | 1 | 2005 | 847 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2025 | 2947 | 0.030 |
Why?
| | Models, Biological | 1 | 2005 | 1822 | 0.030 |
Why?
| | Amphiregulin | 1 | 2017 | 27 | 0.030 |
Why?
| | DNA Repair | 1 | 2019 | 256 | 0.030 |
Why?
| | Karnofsky Performance Status | 1 | 2017 | 37 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2020 | 465 | 0.030 |
Why?
| | Jurkat Cells | 1 | 2016 | 114 | 0.030 |
Why?
| | Transcriptome | 1 | 2023 | 1046 | 0.030 |
Why?
| | Leukocyte Common Antigens | 1 | 2016 | 88 | 0.030 |
Why?
| | Embryo, Mammalian | 1 | 2017 | 232 | 0.030 |
Why?
| | Blotting, Western | 2 | 2012 | 1187 | 0.030 |
Why?
| | Cryopreservation | 1 | 2017 | 110 | 0.030 |
Why?
| | A549 Cells | 1 | 2016 | 75 | 0.030 |
Why?
| | HLA-DR Antigens | 1 | 2016 | 220 | 0.030 |
Why?
| | Staining and Labeling | 1 | 2016 | 151 | 0.030 |
Why?
| | Protein Transport | 1 | 2017 | 441 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2017 | 405 | 0.030 |
Why?
| | Chronotherapy | 1 | 2015 | 3 | 0.030 |
Why?
| | ARNTL Transcription Factors | 1 | 2015 | 17 | 0.030 |
Why?
| | Aging | 1 | 2006 | 1966 | 0.030 |
Why?
| | Biological Transport | 1 | 2016 | 418 | 0.030 |
Why?
| | Precision Medicine | 1 | 2019 | 458 | 0.030 |
Why?
| | Pilot Projects | 1 | 2020 | 1890 | 0.030 |
Why?
| | Fluorescent Dyes | 1 | 2016 | 330 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1990 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1371 | 0.030 |
Why?
| | Antigens, CD | 1 | 2016 | 555 | 0.020 |
Why?
| | Gene Deletion | 1 | 2015 | 389 | 0.020 |
Why?
| | Middle Aged | 3 | 2025 | 35928 | 0.020 |
Why?
| | Proteins | 1 | 2019 | 1022 | 0.020 |
Why?
| | Algorithms | 1 | 2020 | 1839 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2015 | 1311 | 0.020 |
Why?
| | Liver | 2 | 2015 | 1888 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2017 | 8279 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4293 | 0.020 |
Why?
| | Olfactory Pathways | 1 | 2011 | 38 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 173 | 0.020 |
Why?
| | Ameloblasts | 1 | 2011 | 1 | 0.020 |
Why?
| | Intestinal Mucosa | 1 | 2017 | 676 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2015 | 302 | 0.020 |
Why?
| | Tooth | 1 | 2011 | 45 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2011 | 117 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 978 | 0.020 |
Why?
| | Mice, Nude | 1 | 2012 | 688 | 0.020 |
Why?
| | Piperazines | 1 | 2012 | 381 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2012 | 1253 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4569 | 0.020 |
Why?
| | Indoles | 1 | 2012 | 501 | 0.020 |
Why?
| | Sulfonamides | 1 | 2012 | 581 | 0.020 |
Why?
| | Pyridines | 1 | 2012 | 605 | 0.020 |
Why?
| | Phosphorylation | 1 | 2012 | 1733 | 0.020 |
Why?
| | Genes, Lethal | 1 | 2006 | 30 | 0.010 |
Why?
| | Keratin-15 | 1 | 2006 | 17 | 0.010 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 1 | 2005 | 25 | 0.010 |
Why?
| | Keratin-5 | 1 | 2006 | 48 | 0.010 |
Why?
| | Cell Growth Processes | 1 | 2005 | 50 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2005 | 153 | 0.010 |
Why?
| | Genes, p53 | 1 | 2005 | 67 | 0.010 |
Why?
| | Keratins | 1 | 2006 | 172 | 0.010 |
Why?
| | Carcinogens | 1 | 2005 | 123 | 0.010 |
Why?
| | Gene Silencing | 1 | 2005 | 205 | 0.010 |
Why?
| | Ki-67 Antigen | 1 | 2004 | 117 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3869 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 2004 | 252 | 0.010 |
Why?
| | Aged | 2 | 2017 | 25947 | 0.010 |
Why?
| | Cell Division | 1 | 2004 | 766 | 0.010 |
Why?
| | Neoplasm Invasiveness | 1 | 2004 | 509 | 0.010 |
Why?
| | DNA Replication | 1 | 2004 | 251 | 0.010 |
Why?
| | Heart | 1 | 2006 | 636 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2004 | 1054 | 0.010 |
Why?
| | Alleles | 1 | 2004 | 881 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2931 | 0.010 |
Why?
| | Young Adult | 1 | 2017 | 14126 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2011 | 6434 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 17101 | 0.010 |
Why?
| | Infant | 1 | 2011 | 10039 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2005 | 2365 | 0.010 |
Why?
|
|
Ihrie's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|